Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using positive pressure therapy to improve lung function after heart surgery

Official title: Comparison Between Two Methods of Positive Pressure Therapy in the Prevention of Pulmonary Complications in the Immediate Postoperative Period of Cardiac Surgery: a Prospective, Randomized Clinical Trial

Run by Federal University of São Paulo · NCT06611527 · Data updated 2026-11-12

This study is testing two types of breathing treatments to see which one helps heart surgery patients recover better and avoid lung problems.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment156 (estimated)
SponsorFederal University of São Paulo
Academic / other
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedJanuary 8, 2025
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedApril 10, 2025
Trial IDNCT06611527 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients in the immediate postoperative period of heart surgery who have risk factors for pulmonary complications.

Probably not a fit

Patients with hemodynamic instability or severe acute arrhythmias may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of two positive pressure therapies, Continuous Positive Airway Pressure (CPAP) and Positive Pressure Support with Positive End-Expiratory Pressure (PS+PEEP), in reducing pulmonary complications in patients recovering from myocardial revascularization and valve surgeries. The study focuses on patients who are at risk of developing respiratory issues post-surgery, particularly those with mild to moderate pulmonary dysfunction. By assessing the incidence of complications, the trial seeks to determine which therapy is more beneficial in the immediate postoperative period.

Why it matters

Potential benefit: If successful, this study could significantly reduce the incidence of pulmonary complications in patients recovering from heart surgery.

How similar studies have gone: Previous studies have shown positive outcomes with similar positive pressure therapies in postoperative care, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Immediate postoperative period of myocardial revascularization and/or valve replacement or plastic surgery;
* Patients in the preoperative period at risk of developing pulmonary complications, characterized by the presence of at least 2 of the following risk factors: age ≥ 70 years, productive cough, diabetes, history of smoking, chronic obstructive pulmonary disease (COPD) defined by forced expiratory volume in 1 second (FEV1) lower than 75% of predicted, body mass index (BMI) ≥ 27 kg/m2, or only FEV1 lower than 80% and FEV1/forced vital capacity (FVC) ratio lower than 70% of predicted; OR patients in the postoperative period (up to 12 hours after extubation) with mild to moderate complications characterized by a pulmonary complication score lower than 3.

Exclusion Criteria:

* Hemodynamic instability characterized by mean arterial pressure (MAP) lower than 60mmHg and/or acute arrhythmia of any etiology;
* Need for intra-aortic balloon;
* Duration of invasive mechanical ventilation exceeding 24 hours after surgery;
* Pulmonary complication score ≥ grade 3;
* Presence of signs of acute respiratory failure, such as respiratory rate (f) ≥ 25 breaths/min and use of accessory muscles;
* Chest tube with air leak;
* Use of a pacemaker or implantable or external cardioverter-defibrillator.

Where it's running

  • Instituto do Coração - HCFMUSP
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.